ArticlePloS one2026

Multi-omics analysis identifies CCNB1 as a cell cycle factor driving glioblastoma progression and its inhibition by resveratrol.

Bohan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.